Neuexcell Therapeutics

Developer of gene therapies for the treatment of neurodegenerative diseases

placeState College, Pennsylvania, United States calendar_todayFounded 2016 groups15 employees language neuexcell.com

Investor mix

7 investors on record; lead investors include Co-win Ventures, Jemincare, Fujian Haixi New Drug Creation.

Investor typeCountShare
Venture capital457%
Other / undisclosed343%
Coming soon